Main Article Content


Background: A protozoane parasite callede Entamoeba histolyticae (Eh) infects Entamoebae histolytica (Eh), a protozoane parasite that causese 100,000 deaths per year frome amebic dysentery and/or livere abscess, has infectede 10% of the entire world'se population. Usuallye, this extracellular parasitee colonizes the colone with high affinity bindinge to MUC2 mucin without causing illness symptoms, but occasionally, Eh invades the colonic mucosae and triggers an agressivee inflammatory responsee. The particulare host-parasite variables requirede for illnesse etiologye are still mostlye unknown. The parasite's cysteine proteasee cleaved thee C-terminus ofe MUC2, that causese the mucus layer to dissolve, followede by adsorption and cytotoxicitye of the mucosal epitheliume, are the disease's hallmark eventse that cause the condition to worsene. Every time a host cell that causes tissue injurye comes into contact with the host, the host generates an excessively inefficient pro-inflammatory responsee. They can cause cell death through phagocytosis, apoptosis, or trogocytosise (the absorption of livinge cells), which may be cruciale for immune evasion, as well as othere detrimental effects that are brought on by their attachment to the host cellse. Immune evasion techniquese are used by Eh to survive and induce diseasee manifestation in the host; these techniquese are the main focuse of this reviewe. eAn estimated 100,000 individualse are predicted to die eache year from E. histolytica infectione, which is thoughte to impact 1% of peoplee. Clinicale manifestations of a mebice infection can range frome mild to severee, causing extraintestinal abscessese and diarrhea. Onlye 20% of those whoe are affectede, like othere infectious diseasese, reportedly exhibite symptoms. The outcomee of an infection is controllede by both the genetic makee-up of the parasitee and the host ase well as environmental factors like the microbiome. Amebic infection goes through a number of critical stages, includinge the degeneratione of the mucosale layer and infiltratione into it, adherencee to the intestinal epitheliume, invasion intoe the tissuese, and diffusione to other organs.


Entamoebae Histolyticae, Immunee EEvasion, Phagocytosise, Apoptosise, Trogocytosise

Article Details

How to Cite
Hassani ALSalami, E. ., Hussein Albu_Saabar, S. R. ., & Najm Abed, H. . (2022). Review On The Role Of Host Immune Response In Protection And Immunopathogenesis During Entamoeba Histolytica. Medical Science Journal for Advance Research, 3(4), 192–200.


  1. Ackers J, Clark CG, Diamond LS, Duchêne M, Cantellano ME, Jackson TF, et al. WHO/PAHO/UNESCO report. A consultation with experts on amoebiasis. Mexico City, Mexico 28-29 January, 1997. Epidemiol Bull (1997) 18:13–4.
  2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet (2012) 380:2095–128.10.1016/S0140-6736(12)61728-0
  3. Ali IK, Clark CG, Petri WA, Jr. Molecular epidemiology of amebiasis. Infect Genet Evol (2008) 8:698–707.10.1016/j.meegid.2008.05.004
  4. Ximénez C, Morán P, Rojas L, Valadez A, Gómez A. Reassessment of the epidemiology of amebiasis: state of the art. Infect Genet Evol (2009) 9:1023–32.10.1016/j.meegid.2009.06.008
  5. Haque R, Ali IM, Sack RB, Farr BM, Ramakrishnan G, Petri WA, Jr. Amebiasis and mucosal IgA antibody against the Entamoeba histolytica adherence lectin in Bangladeshi children. J Infect Dis (2001) 183:1787–93.10.1086/320740
  6. Hung CC, Chang SY, Ji DD. Entamoeba histolytica infection in men who have sex with men. Lancet Infect Dis (2012) 12:729–36.10.1016/S1473-3099(12)70147-0 7. Watanabe K, Gatanaga H, Escueta-de Cadiz A, Tanuma J, Nozaki T, Oka S. Amebiasis in HIV-1-infected Japanese men: clinical features and response to therapy. PLoS Negl Trop Dis (2011) 5:e1318.10.1371/journal.pntd.0001318 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  7. Haghighi A, Kobayashi S, Takeuchi T, Masuda G, Nozaki T. Remarkable genetic polymorphism among Entamoeba histolytica isolates from a limited geographic area. J Clin Microbiol (2002) 40:4081–90.10.1128/JCM.40.11.4081-4090.2002 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  8. Haghighi A, Kobayashi S, Takeuchi T, Thammapalerd N, Nozaki T. Geographic diversity among genotypes of Entamoeba histolytica field isolates. J Clin Microbiol (2003) 41:3748–56.10.1128/JCM.41.8.3748-3756.2003 10. Haque R, Mondal D, Karim A, Molla IH, Rahim A, Faruque AS, et al. Prospective case-control study of the association between common enteric protozoal parasites and diarrhea in Bangladesh. Clin Infect Dis (2009) 48:1191–7.10.1086/597580
  9. Haque R, Huston CD, Hughes M, Houpt E, Petri WA., Jr Amebiasis. N Engl J Med (2003) 348:1565–73.10.1056/NEJMra022710 12. Infectious Disease Surveillance Center, National Institute of Infectious Diseases of Japan. HIV/AIDS in Japan in the Year of 2013. IASR. Vol. 35 (2014). p. 223–4. Available from:
  10. Petri WA, Jr, Haque R, Mann BJ. The bittersweet interface of parasite and host: lectin-carbohydrate interactions during human invasion by the parasite Entamoeba histolytica. Annu Rev Microbiol (2002) 56:39–64.10.1146/annurev.micro.56.012302.160959 [PubMed] [CrossRef] [Google Scholar]
  11. Leippe M. Amoebapores. Parasitol Today (1997) 13:178–83.10.1016/S0169-4758(97)01038-7 [PubMed] [CrossRef] [Google Scholar]
  12. Bruhn H, Riekens B, Berninghausen O, Leippe M. Amoebapores and NK-lysin, members of a class of structurally distinct antimicrobial and cytolytic peptides from protozoa and mammals: a comparative functional analysis. Biochem J (2003) 375:737–44.10.1042/BJ20030250 [PMC free article] [PubMed] [CrossRef] [Google Scholar]
  13. Kelsall BL, Ravdin JI. Degradation of human IgA by Entamoeba histolytica. J Infect Dis (1993) 168:1319–22.10.1093/infdis/168.5.1319 17. Schulte W, Scholze H. Action of the major protease from Entamoeba histolytica on proteins of the extracellular matrix. J Protozool (1989) 36:538–43.10.1111/j.1550-7408.1989.tb01092.x 18. Tran VQ, Herdman S, Torian BE, Reed SL. The neutral cysteine proteinase of Entamoeba histolytica degrades IgG and prevents its binding. J Infect Dis (1998) 177:508–11.10.1086/517388 19. Que X, Reed SL. Cysteine proteinases and the pathogenesis of amebiasis. Clin Microbiol Rev (2000) 13:196–206.10.1128/CMR.13.2.196-206.2000
  14. Tillack M, Biller L, Irmer H, Freitas M, Gomes MA, Tannich E, et al. The Entamoeba histolytica genome: primary structure and expression of proteolytic enzymes. BMC Genomics (2007) 8:170.10.1186/1471-2164-8-170
  15. Lamm ME. Current concepts in mucosal immunity. IV. How epithelial transport of IgA antibodies relates to host defense. Am J Physiol (1998) 274:G614–7.
  16. Haque R, Duggal P, Ali IM, Hossain MB, Mondal D, Sack RB, et al. Innate and acquired resistance to amebiasis in bangladeshi children. J Infect Dis (2002) 186:547–52.10.1086/341566
  17. Haque R, Mondal D, Duggal P, Kabir M, Roy S, Farr BM, et al. Entamoeba histolytica infection in children and protection from subsequent amebiasis. Infect Immun (2006) 74:904–9.10.1128/IAI.74.2.904-909.2006
  18. Abd-Alla MD, Jackson TF, Rogers T, Reddy S, Ravdin JI. Mucosal immunity to asymptomatic Entamoeba histolytica and Entamoeba dispar infection is associated with a peak intestinal antilectin immunoglobulin A antibody response. Infect Immun (2006) 74:3897–903.10.1128/IAI.02018-05
  19. Ravdin JI, Abd-Alla MD, Welles SL, Reddy S, Jackson TF. Intestinal antilectin immunoglobulin A antibody response and immunity to Entamoeba dispar infection following cure of amebic liver abscess. Infect Immun (2003) 71:6899–905.10.1128/IAI.71.12.6899-6905.2003
  20. Kaur U, Sharma AK, Sharma M, Vohra H. Distribution of Entamoeba histolytica Gal/GalNAc lectin-specific antibody response in an endemic area. Scand J Immunol (2004) 60:524–8.10.1111/j.0300-9475.2004.01512.x
  21. Bernin H, Marggraff C, Jacobs T, Brattig N, Le VA, Blessmann J, et al. Immune markers characteristic for asymptomatically infected and diseased Entamoeba histolytica individuals and their relation to sex. BMC Infect Dis (2014) 14:621.10.1186/s12879-014-0621-1
  22. Gay NJ, Gangloff M. Structure and function of toll receptors and their ligands. Annu Rev Biochem (2007) 76:141–65.10.1146/annurev.biochem.76.060305.151318
  23. Bansal D, Ave P, Kerneis S, Frileux P, Boché O, Baglin AC, et al. An ex-vivo human intestinal model to study Entamoeba histolytica pathogenesis. PLoS Negl Trop Dis (2009) 3:e551.10.1371/journal.pntd.0000551
  24. Galván-Moroyoqui JM, Del CarmenDomínguez-Robles M, Meza I. Pathogenic bacteria prime the induction of toll-like receptor signalling in human colonic cells by the Gal/GalNAc lectin carbohydrate recognition domain of Entamoeba histolytica. Int J Parasitol (2011) 41:1101–12.10.1016/j.ijpara.2011.06.003
  25. Kumar H, Kawai T, Akira S. Pathogen recognition by the innate immune system. Int Rev Immunol (2011) 30:16–34.10.3109/08830185.2010.529976
  26. Helk E, Bernin H, Ernst T, Ittrich H, Jacobs T, Heeren J, et al. TNFα-mediated liver destruction by Kupffer cells and Ly6Chi monocytes during Entamoeba histolytica infection. PLoS Pathog (2013) 9:e1003096.10.1371/journal.ppat.1003096
  27. Lotter H, González-Roldán N, Lindner B, Winau F, Isibasi A, Moreno-Lafont M, et al. Natural killer T cells activated by a lipopeptidophosphoglycan from Entamoeba histolytica are critically important to control amebic liver abscess. PLoS Pathog (2009) 5(5):e1000434.10.1371/journal.ppat.1000434
  28. Peterson KM, Shu J, Duggal P, Haque R, Mondal D, Petri WA., Jr Association between TNF-α and Entamoeba histolytica diarrhea. Am J Trop Med Hyg (2010) 82:620–5.10.4269/ajtmh.2010.09-0493.
  29. Sánchez-Guillén Mdel C, Pérez-Fuentes R, Salgado-Rosas H, Ruiz-Argüelles A, Ackers J, Shire A, et al. Differentiation of Entamoeba histolytica/Entamoeba dispar by PCR and their correlation with humoral and cellular immunity in individuals with clinical variants of amoebiasis. Am J Trop Med Hyg (2002) 66:731–7.
  30. Haque R, Mondal D, Shu J, Roy S, Kabir M, Davis AN, et al. Correlation of interferon-γ production by peripheral blood mononuclear cells with childhood malnutrition and susceptibility to amebiasis. Am J Trop Med Hyg (2007) 76:340–4.
  31. Bansal D, Sehgal R, Chawla Y, Malla N, Mahajan RC. Cytokine mRNA expressions in symptomatic vs. asymptomatic amoebiasis patients. Parasite Immunol (2005) 27:37–43.10.1111/j.1365-3024.2005.00739.x
  32. Guo X, Barrosom L, Becker SM, Lyerly DM, Vedvick TS, Reed SG, et al. Protection against intestinal amebiasis by a recombinant vaccine is transferable by T cells and mediated by gamma interferon. Infect Immun (2009) 77:3909–18.10.1128/IAI.00487-09
  33. Guo X, Barroso L, Lyerly DM, Petri WA, Jr, Houpt ER. CD4+ and CD8+ T cell- and IL-17-mediated protection against Entamoeba histolytica induced by a recombinant vaccine. Vaccine (2011) 29:772–7.10.1016/j.vaccine.2010.11.013
  34. Liang SC, Tan XY, Luxenberg DP, Karim R, Dunussi-Joannopoulos K, Collins M, et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med (2006) 203(10):2271–9.10.1084/jem.20061308
  35. Nishida A, Lau CW, Zhang M, Andoh A, Shi HN, Mizoguchi E, et al. The membrane-bound mucin Muc1 regulates T helper 17-cell responses and colitis in mice. Gastroenterology (2012) 142:865–74.e2.10.1053/j.gastro.2011.12.036
  36. Cao AT, Yao S, Gong B, Elson CO, Cong Y. Th17 cells upregulate polymeric Ig receptor and intestinal IgA and contribute to intestinal homeostasis. J Immunol (2012) 189:4666–73.10.4049/jimmunol.1200955
  37. Blaschitz C, Raffatellu M. Th17 cytokines and the gut mucosal barrier. J Clin Immunol (2010) 30:196–203.10.1007/s10875-010-9368-7
  38. Ghadirian E, Denis M. In vivo activation of macrophages by IFN-γ to kill Entamoeba histolytica trophozoites in vitro. Parasite Immunol (1992) 14:397–404.10.1111/j.1365-3024.1992.tb00014.x
  39. Lin JY, Chadee K. Macrophage cytotoxicity against Entamoeba histolytica trophozoites is mediated by nitric oxide from L-arginine. J Immunol (1992) 148:3999–4005.
  40. Espinosa-Cantellano M, Martínez-Palomo A. Pathogenesis of intestinal amebiasis: from molecules to disease. Clin Microbiol Rev (2000) 13:318–31.10.1128/CMR.13.2.318-331.2000
  41. Denis M, Chadee K. Cytokine activation of murine macrophages for in vitro killing of Entamoeba histolytica trophozoites. Infect Immun (1989) 57:1750–6.
  42. Berrilli F, Di Cave D, Cavallero S, D’Amelio S. Interactions between parasites and microbial communities in the human gut. Front Cell Infect Microbiol (2012) 2:141.10.3389/fcimb.2012.00141
  43. Gilchrist CA, Petri SE, Schneider BN, Reichman DJ, Jiang N, Begum S, et al. Role of the gut microbiota of children in diarrhea due to the protozoan parasite Entamoeba histolytica. J Infect Dis (2015).10.1093/infdis/jiv772
  44. Ouwerkerk JP, de Vos WM, Belzer C. Glycobiome: bacteria and mucus at the epithelial interface. Best Pract Res Clin Gastroenterol (2013) 27:25–38.10.1016/j.bpg.2013.03.001
  45. Nakada-Tsukui K, Tsuboi K, Furukawa A, Yamada Y, Nozaki T. A novel class of cysteine protease receptors that mediate lysosomal transport. Cell Microbiol (2012) 14:1299–317.10.1111/j.1462-5822.2012.01800.x
  46. Furukawa A, Nakada-Tsukui K, Nozaki T. Novel transmembrane receptor involved in phagosome transport of lysozymes and β-hexosaminidase in the enteric protozoan Entamoeba histolytica. PLoS Pathog (2012) 8:e1002539.10.1371/journal.ppat.1002539
  47. Furukawa A, Nakada-Tsukui K, Nozaki T. Cysteine protease-binding protein family 6 mediates the trafficking of amylases to phagosomes in the enteric protozoan Entamoeba histolytica. Infect Immun (2013) 81:1820–9.10.1128/IAI.00915-12
  48. Marumo K, Nakada-Tsukui K, Tomii K, Nozaki T. Ligand heterogeneity of the cysteine protease binding protein family in the parasitic protist Entamoeba histolytica. Int J Parasitol (2014) 44:625–35.10.1016/j.ijpara.2014.04.008
  49. Thibeaux R, Weber C, Hon CC, Dillies MA, Avé P, Coppée JY, et al. Identification of the virulence landscape essential for Entamoeba histolytica invasion of the human colon. PLoS Pathog (2013) 9:e1003824.10.1371/journal.ppat.1003824 .